Sales at Zimmer's knees unit rose 7.5% to $706.3 million, compared to analysts' estimate of $702.9 million.
That helped cushion a miss at its hips unit, where sales of $465.3 million compared with estimates of $481.7 million.
The Indiana-based company's third-quarter revenue rose 5% to $1.75 billion, in line with analysts' average estimates.
Zimmer had said earlier that it expects second- and third-quarter revenue to be a "little bit lighter" compared to the first quarter.
The hip and knee implant maker cut its full-year reported revenue forecast to a growth of 6% to 6.5% from 6.5% to 7.0% earlier while backing its full-year profit forecast of $7.47 to $7.57 per share.
Persons:
Zimmer Biomet, Moritz Hager, Zimmer, Johnson, Ivan Tornos, Christy Santhosh, Sriraj
Organizations:
REUTERS, Zimmer Biomet Holdings, Laboratories, Boston, Thomson
Locations:
Winterthur, Switzerland, Indiana, Bengaluru